Recent IMUX News
- Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update • PR Newswire (US) • 10/31/2024 10:30:00 AM
- Immunic to Participate in Industry, Scientific and Investor Conferences in November • PR Newswire (US) • 10/29/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/22/2024 10:45:28 AM
- Immunic Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis • PR Newswire (US) • 10/22/2024 10:30:00 AM
- Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis • PR Newswire (US) • 09/18/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 08:05:53 PM
- Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome • PR Newswire (US) • 09/04/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 12:30:38 PM
- Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September • PR Newswire (US) • 08/28/2024 10:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:17:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 10:45:40 AM
- Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update • PR Newswire (US) • 08/08/2024 10:30:00 AM
- Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update • PR Newswire (US) • 08/01/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/24/2024 08:11:28 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/24/2024 08:10:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 10:40:20 AM
- Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec • PR Newswire (US) • 07/24/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 12:31:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 10:40:33 AM
- Immunic Appoints Jason Tardio as Chief Operating Officer and President • PR Newswire (US) • 07/09/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:08:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:07:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:05:58 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/10/2024 08:05:34 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM